| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.37B | 2.28B | 2.47B | 2.18B | 1.91B | 2.35B |
| Gross Profit | 944.00M | 1.13B | 1.17B | 1.04B | 988.25M | 1.09B |
| EBITDA | 197.00M | 141.00M | 202.00M | 146.30M | 96.72M | -182.87M |
| Net Income | 64.00M | 5.00M | 91.00M | 33.00M | -42.89M | -343.00M |
Balance Sheet | ||||||
| Total Assets | 2.15B | 2.17B | 2.22B | 2.18B | 2.17B | 2.60B |
| Cash, Cash Equivalents and Short-Term Investments | 109.00M | 116.00M | 116.00M | 140.24M | 197.88M | 414.69M |
| Total Debt | 127.00M | 76.00M | 96.00M | 128.29M | 263.52M | 464.36M |
| Total Liabilities | 1.59B | 1.63B | 1.71B | 1.94B | 2.06B | 2.40B |
| Stockholders Equity | 563.00M | 545.00M | 513.00M | 242.01M | 109.04M | 202.42M |
Cash Flow | ||||||
| Free Cash Flow | 59.00M | 25.00M | -45.00M | -4.20M | -59.75M | -149.48M |
| Operating Cash Flow | 144.00M | 113.00M | 33.00M | 51.22M | 55.00K | -53.95M |
| Investing Cash Flow | -76.00M | -62.00M | 39.00M | 36.33M | 39.77M | 278.94M |
| Financing Cash Flow | -66.00M | -31.00M | -60.00M | -152.36M | -208.02M | -65.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | €4.21B | 14.48 | 14.99% | 1.95% | 8.15% | 16.17% | |
75 Outperform | €669.12M | 19.23 | 47.28% | 5.13% | 7.24% | 22.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | €439.46M | 6.81 | 8.07% | ― | 5.97% | ― | |
54 Neutral | €1.71B | -53.47 | -7.86% | 3.12% | -18.21% | -137.62% | |
52 Neutral | €150.38M | -9.76 | -4.67% | ― | 4.81% | 75.36% |